Advantage of in vivo chemosensitivity assay to detect vincristine-resistance in a human epidermoid carcinoma xenograft

Anticancer Research

Volumn 16, Issue 2, 1996, Pages 729-734

  Abe, Yoshiyuki ^a   Yamazaki, Hitoshi ^a   Oshika, Yoshiro ^a   Suto, Ryuji ^a   Tsugu, Atsushi ^a   Ota, Eiichiro ^a   Satoh, Hidesuke ^a   Ohnishi, Yasuyuki ^b   Yanagawa, Tadashi ^d   Ueyama, Yoshito ^a,b,c   Tamaoki, Norikazu ^a   Nakamura, Masato ^a,c  

^a TOKAI UNIVERSITY   (Japan)

^b CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^c KANAGAWA ACADEMY OF SCIENCE AND TECHNOLOGY   (Japan)

^d SRL INC   (Japan)

Author keywords

Drug resistance; MDR1; P glycoprotein; Xenograft

Indexed keywords

CYCLOSPORIN A; DOXORUBICIN; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; EXPERIMENTAL NEOPLASM; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 8944227978     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Fojo AT, Whang-Peng J, Gottesman MM and Pastan I: Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 82: 7661-7665, 1985.
2. Ueda K, Clark DP, Chen C, Roninson IB, Gottesman MM and Pastan I: The human multidrug resistance (MDR1) gene. J Biol Chem 262: 505-508, 1987.
3. Chen C, Clark D, Ueda K, Pastan I, Gottesman MM and Roninson IB: Genomic organization of the human multidrug P3 resistance (MDR1) gene and origin of P-glycoprotein. J Biol Chem 265: 506-514, 1990.
4. Roninson IB: Molecular and cellular biology of multidrug resistance in tumor cells, pp. 91-104, Plenum, New York, 1991.
5. Chen C, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, and Roninson IB: Internal duplication and homology with bacterial transport proteins in the MDR1 (Pglycoprotein) gene from multidrug-resistant human cells. Cell 47: 381-389, 1986.
6. Gros P, Neriah YB, Croop JM and Housman DE Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 323: 728-731, 1986.
7. Horton J, Houghton J and Houghton P: Expression of multidrug resistance gene (MDR1) in human xenografts selective or resistant to natural products. Proceedings of Am Assoc Cancer Res 29: 317, 1988.
8. Starling JJ, Maciak RS, Hinson NA, Hoskins J, Laguzza BC, Gadski RA, Strnad J, Rittman-Grauer L, Deherdt SV, Bumol TF and Moore R: In vivo selection of human tumor cells resistant to monoclonal antibody-Vinca alkaloid immunoconjugates. Cancer Res 50: 7634-7640, 1990.
9. Akiyama S, Fojo A, Hanover JA, Pastan I and Gottesman MM: Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somatic Cell Mol Gene 11: 117-126, 1985.
10. Fojo A, Akiyama S, Gottesman MM and Pastan I: Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines. Cancer Res 45: 3002-3007, 1985b.
11. Shen D, Cardarelli CC, Hwang J, Cornwell M, Richert N, Ishii S, Pastan I and Gottesman MM: Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinbiastine show changes in expression of specific proteins. J Biol Chem 261: 7762-7770, 1986a.
12. Ueda K, Cardrelli C, Gottesman MM and Pastan I: Expression of a full-length cDNA for the human "MDRI" gene confers resistance to colchicine, doxoruhicin, and vinhlasline. Proc Natl Acad Sci USA 84: 3004-3008, 1487.
13. Abe Y, Nakamura M, Ohnishi Y, Inaba I, Ueyama Y and Tamaoki N: Multidrug resistance gene (MDRI) expression in human tumor xenografts. Int J Oncol 5: 1285-1292, 1994.
14. Abe Y, Nakamura M, Saegusa R, Ueyama Y, Ogata T and Tamaoki N: In vivo acquired drug resistance and multidrug resistance gene (MDRI) expression in the KB carcinoma cell line xenotransplanted in nude mice. Tokai J Exp Clin Med 18: 99-106, 1993.
15. Baker F, Spitzer G, Ajani J, Brock WA, Lukeman J, Pathak S, Barbara T, Thielvoldt D, Williams M, Vines C and Tofilon P: Successful primary monolaver culturing of human tumor cells using cell-adhesive matrix and supplemented medium: Drug and radiation sensitivity measurements. Cancer Res 46: 1263-1274, 1986.
16. Inaba M, Kobayashi T, Tashiro T, Sakurai Y, Maruo K, Ohnishi Y, Ueyama Y and Nonnira T: Evaluation of antitumor activity in a human breast tumor/nude mouse model with a special emphasis on treatment dose. Cancer 64: 1577-1582, 1989.
17. Noonan KE, Beck C, HoIzmer TA, Chin JE, Wunder JS, Andrulis IE, Gazder AF, Willman CE, Griffith B, Von Hoff DD and Roninson IB: Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87: 7160-7164, 1990.
18. Abe Y, Nakamura M, Ota E, Ozeki Y, Tamai S, Inoue H, Ueyama Y, Ogata T and Tamaoki N: Expression of the multidrug resistance gene (MDR1) in non-small cell lung cancer. Jpn J Cancer Res 85: 536-541, 1994a.
19. Ota E, Abe Y, Oshikii Y, Ozeki Y, Iwasaki M, Inoue H, Yamazaki H, Ueyama Y, Takagi K, Ogata T, Tamaoki N and Nakamura M: Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. Br J Cancer 72: 550-554, 1995.
20. Roninson IB, Chin JE, Choi K, Gros P, Housman DE, Fojo A, Shen D, Gottesman MM and Pastan I: Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 83: 4538-4542, 1986.
21. Shen D, Fojo A, Chin JE, Roninson IB, Richert N, Pastan I and Gottesman MM: Human multidrug resislant cell lines: Increased MDR1 expression can precede gene amplification. Science 232: 643-645, 1986.
22. Ajani JA, Baker FL, Spitzer G, Kelly A, Brock W, Tomasovic B, Singletary, SE, McMurtrey M and Plager C: Comparison between clinical response and in vitro drug sensitivity of primary human tumors in the adhesive tumor cell culture system. J Clin Oncol 5: 1912-1921, 1987.
23. Chen H, Bamberger U, Heckel A, Guo X and Cheng: BIBW 22, dipyridamolc analogue, acts as a bifunctional modulator on tumor cells by influencing both P-glycoprotcin and nucleoside transport. Cancer Res 53: 1974-1977, 1993.
24. Smith CD, Carmeli S, Moore RE and Patterson GME: Scytophycins, novel microfilament-depolymerizing agents which circumvent P-glycoprotein-mediated multidrug resistance. Cancer Res 53: 1343-1347, 1993.